Profil Neuropati Perifer dan Korelasinya dengan Kadar Gula Darah Sewaktu di Panti Lansia Santa Anna

Alfred Sutrisno Sim, Dean Ascha Wijaya, Fernando Nathaniel, Giovanno Sebastian Yogie, Yohanes Firmansyah, Hans Sugiarto, Stephanie Amadea, Alexander Halim Santoso

Sari


ABSTRACT

 

Diabetes, as a global disease, continues to increase worldwide without being limited by location. The burden of diabetes in the elderly population is a significant health issue. Peripheral neuropathy caused by diabetes is strongly associated with physical limitations in older individuals. This cross-sectional study aims to determine the characteristics of peripheral neuropathy in participants who meet the criteria, using a total sampling at Santa Anna on July 15, 2023, and explore its correlation with blood sugar levels. Evaluation of sensory and motor clinical symptoms using Neuropathy Symptom Score (NSS) questionnaire. Abnormal reflexes and sensory function were assessed using Neuropathy Deficit Score (NDS) questionnaire. Blood sugar levels were measured using POCT method following standard procedures. Statistical analysis using the Kruskall Wallis test. Out of the 68 participants, the average age was 74.06 years, with 67.6% of the participants being female. The overall average blood sugar level was found to be 115.82 mg/dL. Based on the NSS and NDS classifications, 8.8% and 23.5% of the total participants were categorized as having severe symptoms, respectively. The statistical analysis revealed a significant difference in mean blood sugar levels between the NSS groups (p-value: 0.003). However, no significant difference was observed in mean blood glucose levels between the NDS groups (p-value: 0.264). Clinically, the severe symptom group had a higher median blood glucose level compared to the normal group. It is noteworthy that elevated transient blood sugar levels tend to impact the subjective symptoms (NSS) of peripheral neuropathy earlier than the objective symptoms (NDS).

 

Keywords: Blood Glucose, Clinical Symptom, Peripheral Neuropathy

 

 

ABSTRAK

 

Sebagai penyakit yang tersebar di seluruh dunia, diabetes terus berkembang tanpa memandang tempat dengan jumlah pasien yang semakin meningkat. Beban diabetes pada populasi lanjut usia merupakan masalah kesehatan yang krusial. Neuropati perifer yang diakibatkan oleh diabetes dikaitkan dengan disabilitas fisik yang signifikan pada populasi lanjut usia. Penelitian potong lintang ini bertujuan untuk mengetahui profil neuropati perifer pada responden yang memenuhi kriteria dengan menggunakan total sampling di Panti Santa Anna pada 15 Juli 2023 serta korelasinya dengan kadar gula darah sewaktu. Evaluasi gejala klinis sensorik dan motorik menggunakan kuesioner Neuropathy Symptom Score (NSS). Refleks tidak normal dan penilaian sensorik dieevaluasi menggunakan kuesioner Neuropathy Deficit Score (NDS). Gula darah sewaktu diukur menggunakan POCT sesuai prosedur standar. Analisis statistik menggunakan uji Kruskall Wallis. Dari 68 responden, rata-rata usia adalah 74,06 tahun dengan 67,6% responden adalah perempuan. Dari seluruh responden, didapatkan rata-rata gula darah sewaktu sebesar 115,82 mg/dL. Berdasarkan NSS dan NDS, persentase responden yang termasuk dalam klasifikasi berat adalah sebesar 8,8% dan 23,5% dari keseluruhan responden. Hasil uji statistik Kruskall Wallis menyatakan adanya perbedaan rerata kadar gula darah sewaktu antar kelompok NSS (p-value : 0,003). Namun, didapatkan tidak adanya perbedaan rerata kadar gula darah sewaktu antar kelompok NDS (p-value : 0,264). Secara klinis, kelompok dalam kategori berat memiliki nilai median kadar gula darah sewaktu lebih tinggi dibanding kelompok normal. Kadar gula darah sewaktu yang tinggi cenderung mempengaruhi gejala subjektif (NSS) dari neuropati perifer terlebih dahulu dibandingkan dengan gejala objektif (NDS) dari neuropati perifer.

 

Kata Kunci: Gejala Klinis, Gula Darah, Neuropati Perifer


Kata Kunci


Gejala klinis; Gula darah; Neuropati perifer

Teks Lengkap:

Download Artikel

Referensi


Ang, L., Jaiswal, M., Martin, C., & Pop-Busui, R. (2014). Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials. Current Diabetes Reports, 14(9), 528. https://doi.org/10.1007/s11892-014-0528-7

Baderca, F., Timar, B., Popescu, S., Simu, M., Diaconu, L., Velea, I., & TIMAR, R. (2016). Age as an independent factor for the development of neuropathy in diabetic patients. Clinical Interventions in Aging, 313. https://doi.org/10.2147/CIA.S97295

Callaghan, B. C., Little, A. A., Feldman, E. L., & Hughes, R. A. (2012). Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD007543.pub2

D’Souza, M., Kulkarni, V., Bhaskaran, U., Ahmed, H., Naimish, H., Prakash, A., Tabreez, S., Dahiya, B., Thapar, R., Mithra, P., Kumar, N., Holla, R., Darshan, B., & Kumar, A. (2015). Diabetic Peripheral Neuropathy and Its Determinants among Patients Attending A Tertiary Health Care Centre in Mangalore, India. Journal of Public Health Research, 4(2), jphr.2015.450. https://doi.org/10.4081/jphr.2015.450

Elafros, M. A., Andersen, H., Bennett, D. L., Savelieff, M. G., Viswanathan, V., Callaghan, B. C., & Feldman, E. L. (2022). Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. The Lancet Neurology, 21(10), 922–936. https://doi.org/10.1016/S1474-4422(22)00188-0

Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019). Diabetic neuropathy. Nature Reviews Disease Primers, 5(1), 41. https://doi.org/10.1038/s41572-019-0092-1

Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017). New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron, 93(6), 1296–1313. https://doi.org/10.1016/j.neuron.2017.02.005

GRADE Study Research Group. (2022). Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes. New England Journal of Medicine, 387(12), 1075–1088. https://doi.org/10.1056/NEJMoa2200436

Han, L., Ji, L., Chang, J., Wen, J., Zhao, W., Shi, H., Zhou, L., Li, Y., Hu, R., Hu, J., & Lu, B. (2015). Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome. Diabetology & Metabolic Syndrome, 7(1), 14. https://doi.org/10.1186/s13098-015-0010-y

Hanewinckel, R., Drenthen, J., van Oijen, M., Hofman, A., van Doorn, P. A., & Ikram, M. A. (2016). Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology, 87(18), 1892–1898. https://doi.org/10.1212/WNL.0000000000003293

Jende, J. M. E., Groener, J. B., Oikonomou, D., Heiland, S., Kopf, S., Pham, M., Nawroth, P., Bendszus, M., & Kurz, F. T. (2018). Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography. Annals of Neurology, 83(3), 588–598. https://doi.org/10.1002/ana.25182

Lee, W.-J., Jang, S., Lee, S.-H., & Lee, H.-S. (2016). Correlation Between the Severity of Diabetic Peripheral Polyneuropathy and Glycosylated Hemoglobin Levels: A Quantitative Study. Annals of Rehabilitation Medicine, 40(2), 263. https://doi.org/10.5535/arm.2016.40.2.263

Loscalzo, J., Fauci, A., Kasper, D., Hauser, S., Longo, D., & Jameson, J. L. (2022). Harrison’s Principles of Internal Medicine. McGraw-Hill Education. http://accessmedicine.mhmedical.com/content.aspx?aid=1197731241

Martin, C. L., Albers, J. W., & Pop-Busui, R. (2014). Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care, 37(1), 31–38. https://doi.org/10.2337/dc13-2114

Meijer, J.-W. G., Bosma, E., Lefrandt, J. D., Links, T. P., Smit, A. J., Stewart, R. E., van der Hoeven, J. H., & Hoogenberg, K. (2003). Clinical Diagnosis of Diabetic Polyneuropathy With the Diabetic Neuropathy Symptom and Diabetic Neuropathy Examination Scores. Diabetes Care, 26(3), 697–701. https://doi.org/10.2337/diacare.26.3.697

Nanayakkara, N., Curtis, A. J., Heritier, S., Gadowski, A. M., Pavkov, M. E., Kenealy, T., Owens, D. R., Thomas, R. L., Song, S., Wong, J., Chan, J. C.-N., Luk, A. O.-Y., Penno, G., Ji, L., Mohan, V., Amutha, A., Romero-Aroca, P., Gasevic, D., Magliano, D. J., … Zoungas, S. (2021). Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia, 64(2), 275–287. https://doi.org/10.1007/s00125-020-05319-w

Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042

Zamroni, Asmedi, A., & Nuradyo, D. (2016). Neuropathy symptom score dan neuropathy deficit score sebagai skor diagnostik neuropati diabetik. Berkala Neurosains, 15(1), 46–53.

Zenker, J., Ziegler, D., & Chrast, R. (2013). Novel pathogenic pathways in diabetic neuropathy. Trends in Neurosciences, 36(8), 439–449. https://doi.org/10.1016/j.tins.2013.04.008

Zochodne, D. W. (2016). Sensory Neurodegeneration in Diabetes (pp. 151–180). https://doi.org/10.1016/bs.irn.2016.03.007




DOI: https://doi.org/10.33024/mnj.v5i9.11121

Refbacks

  • Saat ini tidak ada refbacks.


Penerbit: Universitas Malahayati

 Creative Commons License

Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License